Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah's School Awarded 2014 National Education Award

Hadassah’s Experimental School (HES), which provides hospitalized children of all ages and backgrounds with an education in its unique hospital-based school, has been honored with Israel’s National Education Award by the Ministry of Education.

Mrs. Edna Pinchover, HES principal, along with two students from the oncology ward, received the prestigious award from Education Minister MK Shai Piron, in a celebratory ceremony held this month. “We received a tremendous round of applause,” relates Mrs. Pinchover. “As the founder of this unique school, it was truly heartwarming to see our staff and children receive this wonderful recognition, especially from Minister Piron himself.”

Hadassah enables women to expand their horizons, take charge of their lives and provides opportunities to study Judaism, Zionism, Jewish history, Hebrew, literature and culture.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

With a team of teachers, nurses, and volunteers, the children are taught in their native language: Hebrew, Arabic and English. A significant portion of the curriculum centers around cooking, since when the children cook the food themselves, they are motivated to eat, whereas they tend to have poor appetites otherwise. At the same time, math and reading are integrated into the cooking lessons.

Prof. Eitan Kerem, Director of Hadassah’s Division of Pediatrics, emphasizes the vital role that HES plays in the healing and rehabilitation process for young patients. He notes: “Patients in our pediatric ward are, first and foremost, children. They deserve a normal childhood, including an elementary education. Even as patients, the constant connection with a “healthy lifestyle” is an important piece of their complete recovery. Hadassah’s Experimental School creates a unique and vital opportunity for children to thrive within an educational framework, while taking their current state and health into consideration.”

Date: 6/19/2014

Hadassah Stem Cell Expert Speaks at TEDx Conference in Jaffa

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadassah Physicians Receive Prestigious Grants and Awards

New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia

From Life-Threatening Brain Bleed to Birth of a Daughter

Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice

Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum

Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America